Table 1.
Patient characteristics n = 75 patients
| Age (avg ± SD) | 64 ± 19 | |
|---|---|---|
| Grade | I | 6 |
| II | 22 | |
| III | 30 | |
| NA | 17 | |
| Lymph node status | Pos | 47 |
| Neg | 25 | |
| NA | 3 | |
| ER | Pos | 44 |
| Neg | 31 | |
| PgR | Pos | 32 |
| Neg | 43 | |
| HER-2/neu | Pos | 30 |
| Neg | 45 | |
| TNBC | 20 | |
| TPBC | 11 |
NA: not available, ER: estrogen receptor, PgR: progesterone receptor, HER-2/neu: human epidermal growth factor receptor-2, TNBC: triple negative breast cancer, TPBC: triple positive breast cancer.